Home > Balance Sheet > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Net Current Assets

    Back to Balance Sheet
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

EMCURE PHARMACEUTICALS Last 5 Year Net Current Assets History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Current Assets (Including Current Investments) ₹1,888 Cr₹1,044 Cr₹817 Cr₹459 Cr₹309 Cr

What is the latest Net Current Assets ratio of EMCURE PHARMACEUTICALS ?

The latest Net Current Assets ratio of EMCURE PHARMACEUTICALS is ₹1,888 Cr based on Mar2025 Consolidated results.
Year Net Current Assets
Mar2025₹1,888 Cr
Mar2024₹1,044 Cr
Mar2023₹817 Cr
Mar2022₹459 Cr
Mar2021₹309 Cr

How is Net Current Assets of EMCURE PHARMACEUTICALS Trending?

Years Net Current Assets % Change
Mar2025 ₹1,888 Cr
80.80
Mar2024 ₹1,044 Cr
27.83
Mar2023 ₹817 Cr
77.83
Mar2022 ₹459 Cr
48.50
Mar2021 ₹309 Cr -

Compare Net Current Assets of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹29,355.8 Cr -2.9% 6.5% 55.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,603.0 Cr -5.6% -2.5% -1.7% Stock Analytics
DIVIS LABORATORIES ₹155,485.0 Cr -2.6% -8.7% 1.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,009.0 Cr -7.2% -8% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,628.0 Cr -6.5% -5.4% 3.9% Stock Analytics
CIPLA ₹96,400.8 Cr -4.1% -11.5% -19% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

-2.9%

6.5%

55.1%

SENSEX

-1%

-10.9%

-6%


You may also like the below Video Courses